LOS ANGELES, CA (NAMC) - The Securities and Exchange Commission has issued a 10 day trading suspension against IMPAX Laboratories, Inc. (PINK SHEETS:IPXL). The technology based specialty pharmaceutical company has failed to file their reports since September 2004 an din light of that the SEC has ordered an administrative proceeding to determine whether they should suspend or revoke the registration of their securities.

IMPAX has strategic alliances with the likes of Teva Pharmaceuticals (NASDAQ: TEVA) and has had a tough time figuring out how to treat their revenue accounting wise, so it may be in their best interest to comply with what the SEC is requesting because the alternative is a potential revocation of its securites 

Currently trading will be halted on their securities until January 17, 2006, at which time shareholders may be able to trade IMPAX if market makers are active.

David Kingston
Business News Correspondent
NAMC Newswire
www.namcnewswire.com

NAMC Newswire Note: The 2007 "Wall Street to Main Street" Contest is underway and is only  available to subscribers. Keep in mind that all subscriptions are free, all that you need to do is go to www.namcnewswire.com/contest and add your email address, its simple, quick and FREE. You can win one of the many prizes being offered from an iPod, Zune to various gift cards from select retailers..

This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswire.
 
Wall Street to Main Street is also one of the leading shows on StreetIQ , the leader in financial podcast: http://www.streetiq.com/dir/NAMC.shtml

Also be sure to listen to the "Wall Street to Main Street" radio show that is syndicated daily. Just visit the NAMC radio at www.namcnewswire.com/namcradio. 

U.S. Trade Delegations to China scheduled for 2007, Small and Mid Cap Public and Private U.S. Companies are the Focus of the trips: www.namcworldwide.com/conferences